Cluster Headache Syndrome Pipeline Review H2, 2017 – Pharmaceutical Pipeline Guide

Posted on 2017-07-31 by Mark Hub in Healthcare // 0 Comments

Market Research HUB

Albany, US, 2017-Jul-31 — /EPR Network/ —Market Research Hub’s latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome Pipeline Review, H2 2017, provides an overview of the Cluster Headache Syndrome pipeline landscape. A cluster headache is pain that occurs along one side of the head. It is frequently occurs around, behind, or above the eye. Symptoms include burning, sharp, steady pain, red eye, runny nose, excessive tearing and flushed face. Risk factors include age and gender. Treatment includes anti-inflammatory (steroid) medicines and triptans.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1256894

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Cluster Headache Syndrome – Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Cluster Headache Syndrome (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 2, 3 and 1 respectively.

Cluster Headache Syndrome (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope:

– The pipeline guide provides a snapshot of the global therapeutic landscape of Cluster Headache Syndrome (Central Nervous System).

– The pipeline guide reviews pipeline therapeutics for Cluster Headache Syndrome (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Cluster Headache Syndrome (Central Nervous System) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Cluster Headache Syndrome (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Cluster Headache Syndrome (Central Nervous System)

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/cluster-headache-syndrome-pipeline-review-h2-2017-report.html

Reasons to Buy:

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Cluster Headache Syndrome (Central Nervous System).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Cluster Headache Syndrome (Central Nervous System) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content:

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cluster Headache Syndrome – Overview
Cluster Headache Syndrome – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Cluster Headache Syndrome – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cluster Headache Syndrome – Companies Involved in Therapeutics Development
Center Laboratories Inc
Eli Lilly and Company
Novartis AG
Teva Pharmaceutical Industries Ltd
TrioxBio Inc
Cluster Headache Syndrome – Drug Profiles
fremanezumab – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
galcanezumab – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MTR-108 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pasireotide – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
verapamil hydrochloride – Drug Profile
Product Description
Mechanism Of Action
R&D Progress

Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1256894

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick